Gene patenting and medical research: a view from a pharmaceutical company

被引:0
|
作者
Mike Stott
Jill Valentine
机构
[1] Corporate Intellectual Property,
[2] GlaxoSmithKline plc,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Recent reports on gene patenting claim that it has had a negative impact on medical research and have advocated changes in the law to address the negative effects the authors perceive to exist. These reports are based on anecdotal rather than objective evidence. In this article we seek to evaluate the impact of gene patenting objectively by examining, in overall terms, whether there has been a net cost or benefit to medical research from gene patenting.
引用
收藏
页码:364 / 368
页数:4
相关论文
共 50 条
  • [41] Academic Medical Center Leadership on Pharmaceutical Company Boards of Directors
    Anderson, Timothy S.
    Dave, Shravan
    Good, Chester B.
    Gellad, Walid F.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 311 (13): : 1353 - 1355
  • [42] CLINICAL RESEARCH - THE PHARMACEUTICAL INDUSTRYS POINT OF VIEW
    MILLS, FJ
    ARCHIVES OF EMERGENCY MEDICINE, 1985, 2 (03): : 113 - 120
  • [43] Pharmaceutical companies and medical students: a student's view
    Hutchinson, M
    MEDICAL JOURNAL OF AUSTRALIA, 2004, 180 (08) : 414 - 414
  • [44] The effect of educational gifts from pharmaceutical firms on medical students' recall of company names or products
    Sandberg, WS
    Carlos, R
    Sandberg, EH
    Roizen, MF
    ACADEMIC MEDICINE, 1997, 72 (10) : 916 - 918
  • [45] THE PHARMACEUTICAL-MEDICAL RESEARCH FOUNDATION
    不详
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1948, 136 (01): : 42 - 42
  • [46] Medical ethics, research and the pharmaceutical industry
    Abud-Mendoza, Carlos
    REUMATOLOGIA CLINICA, 2012, 8 (05): : 233 - 235
  • [47] Validity of tools used for surveying physicians about their interactions with pharmaceutical company: A systematic review Medical Research Methodology
    Lotfi T.
    Morsi R.Z.
    Zmeter N.
    Godah M.W.
    Alkhaled L.
    Kahale L.A.
    Nass H.
    Brax H.
    Fadlallah R.
    Akl E.A.
    BMC Research Notes, 8 (1)
  • [48] Can the pharmaceutical industry embrace comparative effectiveness research? A view from inside
    Berger, Marc L.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2013, 13 (05) : 565 - 568
  • [49] Patenting inventions arising from biological research
    Latimer, MT
    GENOME BIOLOGY, 2005, 6 (01):
  • [50] Patenting inventions arising from biological research
    Latimer M.T.
    Genome Biology, 6 (1)